Propel Bio Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-750,000	Closed	-$4.65M	–	23
2024 Q2	$4.65M	Hold	750,000	–	–	3.02%	11
2024 Q1	$7.08M	Hold	750,000	–	–	4.12%	8
2023 Q4	$5.06M	Buy	+750,000	New	+$5.06M	4.2%	6